Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELENE 1 trial of AZD6234 in adults with overweight or obesity
jRCT2031260464Recruiting
- Sponsor
- AstraZeneca
- Start
- Sep 2026
- Modality
- Peptides
01
Overview
Randomised, double-blind trial of lenbelintide in obesity and Overweight (3 arms), sponsored by AstraZeneca. Started Sep 2026; status: recruiting.
02
Drugs
lenbelintide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on jRCT2031260464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260464.